DOI:
10.1039/D5QO01273B
(Research Article)
Org. Chem. Front., 2026,
13, 210-215
Nickel-catalyzed C(sp2)–H bond aminoalkylation of alkenes and arenes for the synthesis of δ-amino acid derivatives
Received
8th September 2025
, Accepted 18th October 2025
First published on 21st October 2025
Abstract
We report a highly efficient Ni-catalyzed C(sp2)–H bond aminoalkylation strategy for the synthesis of optically pure amine-containing molecules. This protocol features straightforward operation, readily accessible chiral building blocks derived from natural α-amino acids, and compatibility with late-stage functionalization of drug molecules. Mechanistic investigations reveal a Ni(II)/Mn cooperative catalytic cycle, enabling cross-coupling with β-iodoalkylamines while effectively suppressing β-elimination side reactions. The method exhibits broad substrate scope for both aromatic amides and acrylamides, affording diverse δ-amino acid derivatives in moderate to excellent yields (42–99% yield, up to 99% ee). Notably, gram-scale synthesis and late-stage diversification of bioactive molecules (e.g., estrone, shikimic acid) underscore its synthetic utility.
Introduction
Enantioenriched amines are critical compounds with widespread applications in diverse pharmaceutical agents,1 chiral ligands for asymmetric synthesis,2 and key intermediates for constructing γ- or δ-lactams and highly functionalized piperidine cores3 (Fig. 1). Current methodologies4 primarily rely on asymmetric catalysis5 or stoichiometric functionalization of preformed chiral amines,6 both of which are constrained by limitations in substrate versatility and stereochemical control. Direct functionalization of inert C(sp2)–H bonds with chiral amine surrogates offers a promising alternative, yet challenges persist in achieving high enantioselectivity and suppressing β-hydride or amino elimination during alkylation.7
 |
| | Fig. 1 Representative examples of drugs with chiral amine cores. | |
Nickel-catalyzed C(sp2)–H alkylation mediated by N,N-bidentate directing groups, particularly 8-aminoquinoline auxiliaries, has emerged as a robust platform for C(sp2)–C(sp3) bond construction.8 However, only a few examples of C(sp2)–H bond alkylation with β-functionalized alkyl coupling partners, such as allylation9 and trifluoroethylation,10 have been reported, owing to competing β-elimination pathways (Fig. 2a). Thus, our strategy aims to develop a catalytic system that suppresses undesired β-hydride or amino elimination while enabling C(sp2)–H bond aminoalkylation of alkenes and arenes. This protocol employs readily available chiral building blocks, β-iodoamines derived from natural α-amino acids, to facilitate facile access to enantiopure amines.
 |
| | Fig. 2 Strategy for the synthesis of chiral amines through Ni-catalyzed C–H bond aminoalkylation. | |
Herein, we address these limitations through a Ni(II)/Mn dual catalytic system leveraging β-iodoalkylamines derived from natural α-amino acids. This approach enables enantioselective C(sp2)–H aminoalkylation while circumventing β-hydride or amino elimination, providing a practical route to chiral amines inaccessible via conventional methods (Fig. 2b).
Results and discussion
Our study commenced with evaluating the Ni(II)-catalyzed C(sp2)–H bond aminoalkylation (Table 1). Initially, the reaction of benzamide 1a with β-iodoalkylamine 2a was attempted using Ni(OTf)2/PPh3 as the catalyst and Na2CO3 as the base in toluene at 150 °C for 12 h. However, no desired cross-coupling product 3a was detected (entry 1). We hypothesized that adding a reductant might enhance this conversion, so zinc powder and manganese powder were tested separately. Fortuitously, manganese powder afforded the coupling product 3a in a 23% isolated yield (entry 3). Subsequent solvent screening identified isobutyronitrile (IBN) as the optimal solvent, yielding improved results (entries 3–6). Further evaluation of nickel salts identified the triphenylphosphine-coordinated complex Ni(PPh3)2Cl2 as optimal, increasing the yield of 3a to 61% (entries 5, 7 and 8). Solvent mixing experiments showed that a 1
:
1 (v/v) IBN/toluene mixture was most suitable for this transformation (entries 9–11). Notably, other bidentate directing groups, such as, 2-pyridinylmethylamine (II), 2-aminopyridine (III), and 2-aminopyridine N-oxide (IV), failed to promote this aminoalkylation. The optimized conditions for the Ni(II)-catalyzed C(sp2)–H bond aminoalkylation comprised Ni(PPh3)2Cl2 as the catalyst, Na2CO3 as the base, IBN/toluene (1
:
1 v/v) as the solvent, manganese powder as the reductant, and a reaction temperature of 150 °C for 12 hours, with effective guidance from an 8-aminoquinoline bidentate directing group (see SI for details).
Table 1 Reaction optimizationa
After identifying the optimal conditions (Table 1, entry 10), the scope of aromatic amides was investigated, as shown in Scheme 1. ortho-Aminoalkylation of various benzamides bearing ortho-, meta-, and para-substituted groups generated the corresponding products 3a–k in moderate to excellent yields. We found that para-substituted benzamides 1d–e were prone to double aminoalkylation. By adjusting the amount of benzamides, the products 3d–e of mono-aminoalkylation could be obtained in 70% and 50% yields. For meta-substituted substrates 1f–k, aminoalkylation selectively occurred at the less hindered C–H bonds, with good tolerance to diverse functional groups. Additional aromatic amides, such as 2-naphthamide 1l and 2-thienamide 1m, also furnished cross-coupling products 3l–m. Moreover, the Ni(II)/Mn catalytic system was applied to gram-scale synthesis of product 3h.
 |
| | Scheme 1 Scope of aromatic amides. aReactions were conducted on 0.2 mmol scale under the optimized conditions. Isolated yields. bAromatic amide 1 (0.4 mmol, 2.0 equiv.), β-iodoalkylamine 2a (0.2 mmol, 1.0 equiv.). | |
Next, we expanded the utility of this method by exploring acrylamides (Scheme 2). For α-alkyl-substituted acrylamides 1n–o, E-configured α,β-unsaturated δ-amino acid derivatives 3n–o were obtained in good yields, with the E configuration of 3n confirmed by 2D-NMR (see SI for details). α,β-Di-substituted acrylamides 1p–q also participated efficiently, yielding E/Z mixtures 3p–q in excellent yields, which were readily separated by column chromatography. The predominant formation of the E-isomers from acyclic alkenes 1n–q likely arose from steric and thermodynamic control. Furthermore, cyclic acrylamides 1r–s reacted with β-iodoalkylamine 2a to afford single δ-amino acid derivatives 3r–s, with one product 3s exhibiting >99% ee by HPLC. No racemization of the chiral amine 3s was observed.
 |
| | Scheme 2 Scope of acrylamides. aReactions were conducted on 0.2 mmol scale under the optimized conditions. Isolated yields. bNi(cod)2 (0.1 equiv.) instead of Ni(PPh3)2Cl2 (0.1 equiv.). | |
The potential of this protocol for late-stage functionalization of bioactive molecules was further explored. As revealed in Scheme 3, the chiral amino center could be successfully introduced into the pharmaceutical frameworks of estrone, 16-dehydropregnenolone acetate, (−)-perillic acid, and shikimic acid in 51%, 49%, 61%, and 84% yields, respectively, demonstrating its synthetic utility in organic and pharmaceutical chemistry.
 |
| | Scheme 3 Late-stage diversification of bioactive molecules. Reactions were conducted on 0.2 mmol scale under the optimized conditions. Isolated yields. | |
Chiral β-iodoalkylamines 2b–f, which was readily prepared from natural α-amino acids,11 were employed to explore this aminoalkylation (Scheme 4). To our delight, diverse enantiopure δ-amino acid derivatives 4a–e were synthesized in moderate to excellent yields, with functional groups such as free indole and benzyl hydroxyl groups showing compatibility. Replacing the N-protecting groups of β-iodoalkylamines with dibenzyl (2f) or tert-butoxycarbonyl (2g) abolished cross-coupling.
 |
| | Scheme 4 Scope of β-iodoalkylamines. Reactions were conducted on 0.2 mmol scale under the optimized conditions. Isolated yields. | |
To investigate the reaction mechanism, control experiments were first performed to assess the formation of aminoalkyl manganese species. When β-iodoalkylamine 2b was treated with manganese powder or under standard conditions in an IBN/toluene mixture (Scheme 5a), most of 2b was recovered, ruling out the generation of aminoalkyl manganese intermediates. Next, mechanistic studies focused on identifying the active nickel species (Scheme 5b). Omission of Mn powder reduced the yield to 28%. Using a Ni(0) complex instead of Ni(II)/Mn provided 3a in 52% yield (without Mn), consistent with reports that Ni(I) species are critical in C(sp2)–H alkylation.12
 |
| | Scheme 5 Control experiments. | |
Based on these results and literature precedents,13 a mechanistic hypothesis for this nickel-catalyzed C(sp2)–H bond aminoalkylation reaction is proposed as shown in Fig. 3. First, the nickel(II) precatalyst is reduced to a nickel(I) complex (LnNiIX) via Mn-mediated electron transfer under the assistance of a phosphine ligand, which coordinates with the N,N-bidentate directing group of aromatic amides or acrylamides 1 to form the active intermediate A. Then, N,N-director-assisted C–H activation generates a nickelacycle B under the promotion of sodium carbonate. Next, oxidative addition of B with β-iodoalkylamines 2 generates a nickel(III) intermediate C, which is followed by reductive elimination of C to D, thus forming the C(sp2)–C(sp3) bond. Finally, after the protonolysis of D, the nickel(I) catalyst is regenerated to complete the catalytic cycle.
 |
| | Fig. 3 Mechanistic hypothesis. | |
Conclusions
In summary, we have developed an efficient and practical synthetic method for the preparation of enantiopure amine-containing molecules via Ni-catalyzed C(sp2)–H bond aminoalkylation of aromatic amides and acrylamides with β-iodoalkylamines. This method features a user-friendly catalytic system, readily accessible chiral building blocks derived from natural α-amino acids, and robust stereochemical fidelity (no racemization). Its utility is highlighted by gram-scale synthesis and late-stage functionalization of bioactive pharmaceuticals. Mechanistic studies support a Ni(II)/Mn cooperative cycle involving Ni(I) intermediates, providing insights into C(sp2)–H functionalization pathways. The broad application potential of this method in the synthesis of chiral amine-containing pharmaceuticals and complex molecules is further underscored.
Author contributions
J.-S. T. conceived and supervised the project. R.-Q. Li, D.-Y. L., J.-S. T., J. T. and Y.-X. Y. performed experiments and analyzed the experimental data. D.-Y. L. and R.-Q. Li prepared the ESI. J.-S. T. wrote the paper and T.-P. L. reviewed it. All authors discussed the results and commented on the manuscript.
Conflicts of interest
There are no conflicts to declare.
Data availability
All data associated with this study are available in the article and supplementary information (SI), including additional experimental details, synthetic procedures, and spectroscopic data for all new compounds. Supplementary information is available. See DOI: https://doi.org/10.1039/d5qo01273b.
Acknowledgements
We gratefully acknowledge the Natural Science Basic Research Plan of Shaanxi Province (2023-JC-YB-109), the Fundamental Research Funds for the Central Universities (D5000210701) from the financial support.
References
- For selected examples, see:
(a) N. A. McGrath, M. Brichacek and J. T. Njardarson, A Graphical Journey of Innovative Organic Architectures That Have Improved Our Lives, J. Chem. Educ., 2010, 87, 1348–1349 CrossRef CAS;
(b) E. Vitaku, D. T. Smith and J. T. Njardarson, Analysis of the Structural Diversity, Substitution Patterns, and Frequency of Nitrogen Heterocycles Among U.S. FDA Approved Pharmaceuticals, J. Med. Chem., 2014, 57, 10257–10274 CrossRef CAS PubMed;
(c) S. Zhao and F. A. Etzkorn, Bioorg. Med. Chem. Lett., 2007, 17, 6615–6618 CrossRef CAS PubMed;
(d) X. J. Wang, B. Xu, A. B. Mullins, F. K. Neiler and F. A. Etzkorn, Conformationally Locked Isostere of PhosphoSer-cis-Pro Inhibits Pin1 23-Fold Better than PhosphoSer-trans-Pro Isostere, J. Am. Chem. Soc., 2004, 126, 15533–15542 CrossRef CAS;
(e) Many pharmaceutical molecules are freely accessible to anyone as PDF files at https://njardarson.lab.arizona.edu.
- For selected examples, see:
(a) S. L. Zultanski and G. C. Fu, Catalytic Asymmetric γ-Alkylation of Carbonyl Compounds via Stereoconvergent Suzuki Cross-Couplings, J. Am. Chem. Soc., 2011, 133, 15362–15364 CrossRef CAS;
(b) T. D. Beeson, A. Mastracchio, J.-B. Hong, K. Ashton and D. W. C. MacMillan, Enantioselective Organocatalysis Using SOMO Activation, Science, 2007, 316, 582–585 CrossRef CAS PubMed.
-
(a) S. Y. Hong, Y. Park, Y. Hwang, Y. B. Kim, M.-H. Baik and S. Chang, Selective Formation of γ-Lactams via C-H Amidation Enabled by Tailored Iridium Catalysts, Science, 2018, 359, 1016–1021 CrossRef CAS;
(b) I. S. Hassan, A. N. Ta, M. W. Danneman, N. Semakul, M. Burns, C. H. Basch, V. N. Dippon, B. R. McNaughton and T. Rovis, Asymmetric δ-Lactam Synthesis with a Monomeric Streptavidin Artificial Metalloenzyme, J. Am. Chem. Soc., 2019, 141, 4815–4819 CrossRef CAS PubMed;
(c) Z. Bian, C. C. Marvin, M. Pettersson and S. F. Martin, Enantioselective Total Syntheses of Citrinadins A and B. Stereochemical Revision of Their Assigned Structures, J. Am. Chem. Soc., 2014, 136, 14184–14192 CrossRef CAS PubMed;
(d) A. Trabocchi, F. Guarna and A. Guarna,
γ- and δ-Amino Acids: Synthetic Strategies and Relevant Applications, Curr. Org. Chem., 2005, 9, 1127–1153 CrossRef CAS.
-
T. C. Nugent, Chiral Amine Synthesis: Methods, Developments and Applications, Wiley-VCH, 2010 Search PubMed.
- For selected examples, see:
(a) M.-L. Li, J.-H. Yu, Y.-H. Li, S.-F. Zhu and Q.-L. Zhou, Highly Enantioselective Carbene Insertion into N-H Bonds of Aliphatic Amines, Science, 2019, 366, 990–994 CrossRef CAS PubMed;
(b) T. Deng, X.-L. Han, Y. Yu, C. Cheng, X. Liu, Y. Gao, K. Wu, Z. Li, J. Luo and L. Deng, Organocatalytic Asymmetric α-C–H Functionalization of Alkyl Amines, Nat. Catal., 2024, 7, 1076–1085 CrossRef CAS;
(c) Y.-F. Zhang, B. Wang, Z. Chen, J.-R. Liu, N.-Y. Yang, J.-M. Xiang, J. Liu, Q.-S. Gu, X. Hong and X.-Y. Liu, Asymmetric Amination of Alkyl Radicals with Two Minimally Different Alkyl Substituents, Science, 2025, 388, 283–291 CrossRef CAS;
(d) J.-W. Wang, Y. Li, W. Nie, Z. Chang, Z.-A. Yu, Y.-F. Zhao, X. Lu and Y. Fu, Catalytic Asymmetric Reductive Hydroalkylation of Enamides and Enecarbamates to Chiral Aliphatic Amines, Nat. Commun., 2021, 12, 1313 CrossRef CAS.
- For selected reviews, see:
(a) A. F. M. Noisier and M. A. Brimble, C-H Functionalization in the Synthesis of Amino Acids and Peptides, Chem. Rev., 2014, 114, 8775–8806 CrossRef CAS;
(b) G. He, B. Wang, W. A. Nack and G. Chen, Syntheses and Transformations of α-Amino Acids via Palladium-Catalyzed Auxiliary-Directed sp3 C-H Functionalization, Acc. Chem. Res., 2016, 49, 635–645 CrossRef CAS PubMed;
(c) J. He, M. Wasa, K. S. L. Chan, Q. Shao and J.-Q. Yu, Palladium-Catalyzed Transformations of Alkyl C-H Bonds, Chem. Rev., 2017, 117, 8754–8786 CrossRef CAS PubMed.
- N. D. P. Atmuri and W. D. Lubell, Preparation of N-(Boc)-Allylglycine Methyl Ester Using a Zinc-Mediated, Palladium-Catalyzed Cross-Coupling Reaction, Org. Synth., 2015, 92, 103–116 CrossRef.
- For selected reviews, see:
(a) S. Rej, Y. Ano and N. Chatani, Bidentate Directing Groups: An Efficient Tool in C-H Bond Functionalization Chemistry for the Expedient Construction of C-C Bonds, Chem. Rev., 2020, 120, 1788–1887 CrossRef CAS PubMed;
(b) L. C. M. Castro and N. Chatani, Nickel Catalysts/N,N‘-Bidentate Directing Groups: An Excellent Partnership in Directed C-H Activation Reactions, Chem. Lett., 2015, 44, 410–421 CrossRef CAS;
(c) F. Požgan, U. Grošelj, J. Svete, B. Štefane and H. H. Al Mamari, Recent Advances in the Nickel-Catalyzed Alkylation of C-H Bonds, Molecules, 2024, 29, 1917 CrossRef;
(d) M.-Z. Lu, J. Goh, M. Maraswami, Z. Jia, J.-S. Tian and T.-P. Loh, Recent Advances in Alkenyl sp2 C-H and C-F Bond Functionalizations: Scope, Mechanism and Applications, Chem. Rev., 2022, 122, 17479–17646 CrossRef CAS PubMed;
(e) S. B. Ankade, A. B. Shabade, V. Soni and B. Punji, Unactivated Alkyl Halides in Transition-Metal-Catalyzed C-H Bond Alkylation, ACS Catal., 2021, 11, 3268–3292 CrossRef CAS;
(f) Y.-H. Liu, Y.-N. Xia and B.-F. Shi, Ni-Catalyzed Chelation-Assisted Direct Functionalization of Inert C-H Bonds, Chin. J. Chem., 2020, 38, 635–662 CrossRef CAS. For selected examples, see:
(g) V. Zaitsev, D. Shabashov and O. Daugulis, Highly Regioselective Arylation of sp3 C-H Bonds Catalyzed by Palladium Acetate, J. Am. Chem. Soc., 2005, 127, 13154–13155 CrossRef CAS PubMed;
(h) Y. Aihara and N. Chatani, Nickel-Catalyzed Direct Alkylation of C-H Bonds in Benzamides and Acrylamides with Functionalized Alkyl Halides via Bidentate-Chelation Assistance, J. Am. Chem. Soc., 2013, 135, 5308–5311 CrossRef CAS PubMed;
(i) Y. Aihara, M. Tobisu, Y. Fukumoto and N. Chatani, Ni(II)-Catalyzed Oxidative Coupling between C(sp2)-H in Benzamides and C(sp3)-H in Toluene Derivatives, J. Am. Chem. Soc., 2014, 136, 15509–11551 CrossRef CAS PubMed;
(j) R. C. Samanta, J. Struwe and L. Ackermann, Nickela-electrocatalyzed Mild C-H Alkylations at Room Temperature, Angew. Chem., Int. Ed., 2020, 59, 14154–14159 CrossRef CAS.
-
(a) X. Cong, Y. Li, Y. Wei and X. Zeng, Nickel-Catalyzed C-H Coupling with Allyl Phosphates: A Site-Selective Synthetic Route to Linear Allylarenes, Org. Lett., 2014, 16, 3926–3929 CrossRef CAS PubMed;
(b) S. Asako, L. Ilies and E. Nakamura, Iron-Catalyzed Ortho-Allylation of Aromatic Carboxamides with Allyl Ethers, J. Am. Chem. Soc., 2013, 135, 17755–17757 CrossRef CAS PubMed;
(c) N. Barsu, D. Kalsi and B. Sundararaju, Carboxylate Assisted Ni-Catalyzed C-H Bond Allylation of Benzamides, Chem. – Eur. J., 2015, 21, 9364–9368 CrossRef CAS PubMed.
- W. Song, S. Lackner and L. Ackermann, Nickel-Catalyzed C-H Alkylations: Direct Secondary Alkylations and Trifluoroethylations of Arenes, Angew. Chem., Int. Ed., 2014, 53, 2477–2480 CrossRef CAS PubMed.
-
(a) M. Zheng, W. Xue, T. Xue and H. Gong, Ester Formation via Nickel-Catalyzed Reductive Coupling of Alkyl Halides with Chloroformates, Org. Lett., 2016, 18, 6152–6155 CrossRef CAS PubMed;
(b) Y. Chen, X. Sun, N. Wu, J. Li, S. Jin, Y. Zhong, Z. Liu, A. Rogacheva and H.-S. Chong, Synthetic and Theoretical Investigation on the One-pot Halogenation of β-Amino Alcohols and Nucleophilic Ring Opening of Aziridinium Ions, Org. Biomol. Chem., 2016, 14, 920–939 RSC;
(c) S. C. Söderman and A. L. Schwan, The Diastereoselective Alkylation of Arenesulfenate Anions Using Homochiral Electrophiles, Org. Lett., 2011, 13, 4192–4195 CrossRef PubMed.
-
(a) M. E. Greaves, T. O. Ronson, G. C. Lloyd-Jones, F. Maseras, S. Sproules and D. J. Nelson, Unexpected Nickel Complex Speciation Unlocks Alternative Pathways for the Reactions of Alkyl Halides with dppf-Nickel(0), ACS Catal., 2020, 10, 10717–10725 CrossRef CAS PubMed;
(b) R. Kehoe, M. Mahadevan, A. Manzoor, G. McMurray, P. Wienefeld, M. C. Baird and P. H. M. Budzelaar, Reactions of the Ni(0) Compound Ni(PPh3)4 with Unactivated Alkyl Halides: Oxidative Addition Reactions Involving Radical Processes and Nickel(I) Intermediates, Organometallics, 2018, 37, 2450–2467 CrossRef CAS;
(c) B. R. Reed, S. A. Stoian, R. L. Lord and S. Groysman, The Aldimine Effect in Bis(imino)pyridine Complexes: Non-planar Nickel(I) Complexes of a Bis(aldimino)pyridine Ligand, Chem. Commun., 2015, 51, 6496–6499 RSC.
-
(a) Q.-J. Yao, F.-R. Huang, J.-H. Chen and B.-F. Shi, Nickel(II)/BINOL-Catalyzed Enantioselective C-H Activation via Desymmetrization and Kinetic Resolution, Nat. Commun., 2024, 15, 7135 CrossRef CAS PubMed;
(b) S. Xu, K. Takamatsu, K. Hirano and M. Miura, Nickel-Catalyzed Stereospecific C-H Coupling of Benzamides with Epoxides, Angew. Chem., Int. Ed., 2018, 57, 11797–11801 CrossRef CAS PubMed;
(c) P. Zimmermann and C. Limberg, Activation of Small Molecules at Nickel(I) Moieties, J. Am. Chem. Soc., 2017, 139, 4233–4242 CrossRef CAS.
Footnote |
| † These authors contributed equally to this work. |
|
| This journal is © the Partner Organisations 2026 |
Click here to see how this site uses Cookies. View our privacy policy here.